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•  CLONING: WHAT IS IT?(1) 
 
 The production of multiple, exact copies of a single gene, 
DNA fragment, cell line, or organism. 
 
 3 types of cloning technology today:  
 
I.     Recombinant DNA technology. 
 
II.     Reproductive cloning. 
 
III.     Therapeutic cloning. 
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 DNA cloning is a technique for reproducing DNA         
fragments. 
 (specific part of a DNA or RNA)  
 
• It can be achieved by two different approaches: 
 
 Cell based 
 Using polymerase chain reaction (PCR). 
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Cloning 
tools 
Ligase 
HOST 
Introduce DNA 
to host 
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Endonuclease 
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Cell-Free 
Prokaryotic 
•  Ecoli ,Bacillus… 
Eukaryotic 
• Yeast 
• Insect cell line 
• Mammalian cell 
• Plants 
• Fungi 
VARIOUS EXPRESSION SYSTEMS 
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 • FEATURS OF THE HOST FOR DNACLONING: 
(3) 
 
1. Be easy to handle and propagate. 
2. Have a defined genotype. 
3. Accept a range of vectors. 
4. Produces large amounts of a specific proteins.  
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    Cell-free expression system: (4) 
 
 Since 1950’s ,it has been known that disrupted cell are 
still capable of synthesizing proteins. 
 
 Cell-free expression opens the way to the synthesis of 
unexpected new molecules, such as polypeptides 
containing Non-natural Amino acids.  
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Advantages:(5) 
 
 
  Rapid rout to protein. 
 
 Commercially available. 
  
 Condition of synthesis can be manipulated. 
 
 Can  readily  incorporate  Non-amino acids . 
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Dis advantages: 
 
 Limited post-translational modifications in absence of 
canine pancreatic microsomes. 
 Expensive at scale. 
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Protein Expression in Bacteria(6) 
 
 
 
12 
  
 Advantages: 
  
 Dis advantages: 
  
 Fast growth 
  
 In efficient S-S bound formation 
  
 Cost effective 
  
 Poor folding of proteins in the 
cytoplasm 
 
 High protein yield 
  
 Inclusion body formation 
  
 Simple transformation protocols 
 Codon usage different  
  
 *Endotoxin 
 
 Ability to  host foreign DNA  
 
 Minimal post translational 
modification 
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 E.Coli(3) 
• Is the microorganism of choice for most gene cloning 
experiments.  
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• Glycosylation in Ecoli:(7) 
  N-linked glycosylation not restricted to     
  eukaryote cell, Also was found in    
  Campylobacter jejuni 
 
 Transferred this path way to E.coli. 
14 
 Lactococcus Lactis: (8,9) 
• Generally regarded as safe organism. 
• It can be used for the expression of recombinant protein 
and is capable of secretion. 
    Advantages: 
 vaccine antigens for use in human. 
 have potential for live vaccine design. 
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  Challenges': 
 
 Viability of re-engineered commensal bacteria in mucosal 
compartments. 
 
 Their ability to present the Antigen to the right effector of 
the immune response. 
 
 Possible transmission of pathogenic counterparts of 
selection markers engineer the  strain. 
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    Caulobacter crescentus: (10) 
 
• Is a commercially available expression system, allowing 
production and Easy purification of recombinant protein. 
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   Bacillus: (11) 
 
 
 
   Is an attractive alternative to E. coli because: 
 
 It is suitable for High-density cultures in fermenters. 
 Most of bacillus strain are devoid of membrane  proteases. 
 Bacillus strain are more prone to Secretion than E. Coli 
 A wide variety of expression vectors and strong promoters 
have been documented. 
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    Eukaryotic expression systems:  
 
1. Yeast 
2. Insect cell 
3. Mammalian cell 
4. Plant  
5. Fungi 
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1. Protein expression in the Yeast (12) 
• Advantages: 
 
 Post-translational modifications. 
 Higher protein yields. 
 Secretory pathway is very similar to that in higher 
     eukaryotes. 
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 Challenges: 
 
 Hyper glycosylation (outer chain extension). 
 
 In the yeast Golgi is not typical of  mammalian cells. 
 
 Yeast proteins only modified by manosylation 
     (no other sugars). 
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 Saccharomyces cerevisiae ; (13) 
 
• Has been considered a prototype for many years, but 
other yeast strain have recently become accessible. 
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 Kluyveromyces Lactis 
 Pichia Pastoris 
 Hansenula polymorpha .( is now Pichia.angusta) 
 
 And in several cases these strains have proven to have  
    significant advantages over sccharomyces, both in  
    terms of Production yields an Secretion capacity.  
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 Advantages: 
 
 Dis advantages: 
 
  Good expression level 
 
 Lower expression than Pichia 
  Low cost 
 
 
  Simple culture condition 
 
 
  Glycosylation different to mammalian cell 
 
  Most eukaryotic post-translational 
modification 
 
 
 N-glycan structure considered Allergic 
 
  Efficient protein folding 
 
 
 Endotoxin free 
 
  Secretion lower than Pichia 
 
Saccharomyces: (13) 
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 Yarrowia Lipolytica (14) 
 
• Is also a no conventional yeast strain, capable of 
growing on industrial Fats, in which a large 
number of recombinant proteins have been 
successfully expressed particularly industrial 
enzymes. 
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25 
• methylotrophic yeasts (The yeast has ability to utilize methanol  
      as a sole source of carbon and energy) 
 
 Pichia pastoris  (15 ) 
 
A promoter derived from (AOX1) of  P. pastoris that is 
uniquely suited for the controlled expression of foreign genes; 
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Advantages of Pichia: 
Short doubling time 
Improved folding & post translational modification 
Better yield 
Endotoxin free 
Simple purification 
Dis advantages of Pichia: 
proteolysis 
Glycosylation still different to mammalian cell  (17) 
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o Expression in Insect cell : (18) 
  
insect cell line such as  Baculovirus and High five , SF , … 
have the ability to support cell growth and recombinant  
protein production . 
 
    Advantage over mammalian cells; 
 They have a Stronger viral safety profile than their 
mammalian counterparts. 
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Advantages: 
 
 Good expression levels 
      
      (Especially  for intracellular protein) 
 
 Rapid growth 
 
 Efficient protein folding 
 
 Extensive post translational modification 
 
 Endotoxin Free 
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Dis advantages: 
 
 Expensive culture media 
 
 Large volume of virus needed on scale-up  
 
 Glycosylation different to mammalian cell 
 
 Viral infection leads to cell lysis. 
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30 
o Mammalian expression system: (19,20) 
 
• 1- Cell lines (human , mouse) 
 
• 2- Transgenic animals  
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   Expression in mammalian cells: 
 
 All post translational modification. 
 
 Highest folding capacity(antibodies…) 
 
 Secreted recombinant protein. 
 
 More easier purification than intracellular production. 
 
 Endotoxin-free 
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Dis advantages: 
 
 Lowest yield 
 Expensive culture media. 
 Complex growth requirements. 
 Transfection more complex than plasmid 
transformation. 
 Stable or transient transfection ( takes longer to obtain 
stable transformant) 
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• Several Rodent or Human – drived Cell Like ; 
     3T3, CHO, BHK, Hella and HepG2  
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 Cell lines used. Three cell types are dominant in 
transient expression: HEK and  BHK whilst CHO cells 
are used predominantly for stable expression. (20) 
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CHO Cells ( Chinese Hamster Ovary ) (21) 
• 70% of all recombinant protein therapeutics produced , 
     Today are made in CHO Cells.  (21) 
 
 The first recombinant protein produced in mammalian cell, 
was Tissue plasminogen activator, in the 1987 with using 
CHO Cell. 
 
 
 
 
 
 
24 June 2016 'PROTEIN EXPRESSION SYSTEMS'  
24 June 2016 'PROTEIN EXPRESSION SYSTEMS'  35 
36 
o     Expression in transgenic animals:  
 
• An example is the production of recombinant molecules in 
the mammary glands of transgenic cattle. (22)  
 
• A good illustration is the laborious expression of blood 
clotting factor VIII in the mammary glands of transgenic 
sheep. (23,24) 
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• Other complex molecules like CTLA4Ig are under 
investigation using Transgenic mice as a preliminary 
step. (25) 
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• Dis advantages: 
 
 This approach would be restricted to certain 
pharmaceuticals of very high value. 
 
 Because such an approach has to be carefully considered in 
terms of cost , technical difficulty , and production time among 
other factors  
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    Expression in plant system (26) 
 
 Particularly ,in the field of vaccine production , transgenic 
plants can accommodate the “Edible Vaccine“ concept. 
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Challenges of plant expression systems: 
 
Demonstration of the proof of principle and standardization of the antigen dose. 
 
 
 
Differences in glycosylation patterns . 
 
Subsequent influence on the half-life of injected plant-derived  products . 
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Advantages of plant system: 
Cost effective and simple scale-up. 
Low risk of contamination with animal; pathogens. 
Relatively simple and cheap protein purification. 
 
Expected yields  are >1kg. 
Post translational modifications. 
 
They have a strong viral safety component. 
 
well defined  and industrially compliant culture media. 
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 “plantibodies” inhibit the re colonization  
     of cavities by Streptococcus mutans or 
    elicit mucosal protection against genital herpes. 
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 Expression in fungi: (27,28) 
 
• Aspergillus niger 
• Trichoderma reesei 
• Neurospora crassa 
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Filamentous fungi are wildly used in industry to produce: 
• Antibiotics like Penicillin. 
• Lovastatin. 
• Food ingredient such as citric acid … 
 
• Particularly in the production of industrial enzymes 
 
• Not high enough for commercial exploitation, improved 
strains and processes can lead to enormous yield increases 
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Advantages of fungi system: 
Produce protein in large quantitative. 
Post translational modification. 
Generally regarded as safe. 
Inexpensive. 
Disadvantages: 
Protein of yield are often very Low. 
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Protein expression systems 
SPEED 
COST 
YIELD 
POST-
TRANSLACTION 
MODIFICATION 
LOW HIGH 
Bacteria 
Yeast 
Yeast 
Yeast 
Yeast 
Bacteria 
Bacteria 
Bacteria Mammalian 
Mammalian 
Mammalian 
Mammalian 
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Every protein is Unique and thus requires a    
dedicated strategy for its optimal expression. 
 
24 June 2016 'PROTEIN EXPRESSION SYSTEMS'  
 Conclusion 
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